Jinan Tonglu Pharmaceutical Technology Development

Jinan Tonglu Pharmaceutical Technology Development is a Chinese pharmaceutical research and development company specializing in the development of generic drugs and innovative small molecule therapeutics. The company provides comprehensive contract research organization (CRO) services, including drug synthesis, formulation development, and clinical trial management. Their portfolio primarily focuses on metabolic diseases, cardiovascular health, and anti-infectives, with a strong emphasis on high-barrier generic drugs. Jinan Tonglu is recognized for its technical expertise in navigating the Chinese regulatory landscape and bringing cost-effective pharmaceutical solutions to the domestic market.